Cell Host & Microbe DOI:10.1016/j.chom.2026.05.003 Abstract Microbiota-driven gutbrain signaling underlies antidepressant effects of a GLP-1 analog Despite widespread clinical use of glucagon-like peptide-1 receptor (GLP-1R) agonists for metabolic disease, their neuropsychiatric effects remain poorly understood and controversial
Pharmacy partners dispense medication only after approval, and their identities are not disclosed publicly
Adderalls main objective is to regulate and enhance specific brain chemicals (neurotransmitters), especially dopamine and norepinephrine, and boost their availability in the brain
For people with T2D, a phase 2 trial with mazdutide (doses 3, 4.5 and 6 mg) has shown reduction in HbA1c (up to 1.7%) and up to 7.1% WL at 20 weeks (Table 3), while early phase trials for MASH are in progress [72]
Diabetes-associated excess kidney tissue RAS activation increases angiotensin II-mediated glomerular efferent arteriolar vasoconstriction and glomerular hyperfiltration, tubular sodium reabsorption, and signalling through intracellular pathways, resulting in inflammation and oxidative stress [13]
